SEC Filings
Neuronetics' 21.6% Madryn Stake Faces Sale Restrictions After Its Debt-Funding Offering
Madryn's restrictions extend 30 days beyond the final prospectus, while a separate agreement binds Avinash Amin for 90 days.
Neuronetics (STIM) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Madryn's restrictions extend 30 days beyond the final prospectus, while a separate agreement binds Avinash Amin for 90 days.
SEC Filings
Jorey retained a 2.7% stake as the treatment-system company sought fresh capital and relief from loan requirements.
SEC Filings
The previously priced share offering would help repay loans under a facility carrying an 11.5% interest rate as of September 30.
SEC Filings
The company expects about $27.7 million after expenses, with lender relief tied to a prepayment of at least $15 million.
SEC Filings
Part of the money is intended to repay loans as the company seeks conditional relief from revenue requirements.
SEC Filings
Interest, fees and lender expenses come on top of the minimum payment under the conditional agreement with Perceptive.
Earnings
The company says field reps beat consumer ads on return and will lift its team from 20 to 28 at no added cost.
Earnings
Third-quarter revenue rose to $42.0 million, but the company says a lender could call its debt and raises "substantial doubt."
Earnings
The TMS maker held its 2026 revenue outlook and lowered its spending and cash-burn forecasts after a third quarter that cut its net loss to $1.6 million.